Weight-loss drugs like Ozempic don’t seem to raise suicide risk for most people, but there might be a warning sign for those also taking antidepressants or anxiety meds.

20

Pro

0

Against

Evidence from Studies

Supporting (1)

20

Community contributions welcome

20

Psychiatric effects of GLP‐1 receptor agonists: A systematic review of emerging evidence

Systematic Review

Human

2026 Jan

The study looks at the same diabetes and weight-loss drugs mentioned in the claim and says there's no clear link to suicide risk, which matches what the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Psychiatric effects of GLP‐1 receptor agonists: A systematic review of emerging evidence

Score: 20

DOI: 10.1111/dom.70198

Similar Assertions

For US veterans with type 2 diabetes and a history of substance use, starting a GLP-1 drug (like Ozempic) may lower their chances of overdosing on drugs or having suicidal thoughts compared to starting a different diabetes drug called an SGLT-2 inhibitor.

53

0

80%

Some diabetes drugs called GLP-1 agonists might help with depression symptoms, based on a few studies — but the results aren't clear-cut and more research is needed.

20

0

77%

So far, only one in three studies has found that diabetes drugs called GLP-1 agonists might help with depression, so the proof isn't strong or clear yet.

20

0

75%

People with type 2 diabetes or obesity who take GLP-1 drugs like semaglutide might be less likely to develop depression or anxiety.

50

0

73%

People with type 2 diabetes who take GLP-1 drugs like Ozempic might feel a little better emotionally, but the mood boost is small and doesn’t show up in every study.

20

0

73%